T1	Participants 83 128	Cholesterol and Recurrent Events (CARE) trial
T2	Participants 449 670	Cholesterol and Recurrent Events (CARE) trial, a randomized placebo-controlled trial of pravastatin in 4159 patients with myocardial infarction and average LDL concentrations at baseline (115 to 174 mg/dL, mean 139 mg/dL)
